Marion Wencker

Marion Wencker has a long and varied work experience in the medical field. Marion began their career in 1991 as a Board certified MD (Internal medicine, respiratory diseases, allergology) at the Ruhrlandklinik in Essen. In 2001 they moved to GlaxoSmithKline as Director Medical Affairs Pulmonary Germany. From 2006 to 2011 they were Head of Medical and Clinical Affairs Europe at Talecris Biotherapeutics. In this role they had core responsibilities such as building and leading a new medical and clinical affairs team for Europe, successful European re-launch of two products, and European medical responsibility for plasma derived products in orphan disease indications. In 2012 they moved to CRS Clinical Research Services Mannheim GmbH as Medical Director, Head of Clinical Pharmacology Unit. From 2016 to 2020 they were Managing Director at conresp. Currently, they are Chief Medical Officer at sterna biologicals GmbH.

Marion Wencker obtained their MD from Groote Schur Hospital in 1990, their Dr. med. from The University of Freiburg between 1986 and 1990, and studied Cardiology at Medizinische Universität Innsbruck in 1985-1986.